| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Bmj 372, 2021 | 56428 | 2021 |
| CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials KF Schulz, DG Altman, D Moher Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010 | 21095 | 2010 |
| RoB 2: a revised tool for assessing risk of bias in randomised trials JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ... bmj 366, 2019 | 14814 | 2019 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 11359 | 2016 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 7552 | 2014 |
| The PRISMA, et al. statement: an updated guideline for reporting systematic reviews MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Bmj 2021 (372), 71, 2020 | 6005* | 2020 |
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations B Hutton, G Salanti, DM Caldwell, A Chaimani, CH Schmid, C Cameron, ... Annals of internal medicine 162 (11), 777-784, 2015 | 5425 | 2015 |
| Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration I Boutron, D Moher, DG Altman, KF Schulz, P Ravaud, CONSORT Group* Annals of internal medicine 148 (4), 295-309, 2008 | 2485 | 2008 |
| Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Journal of clinical epidemiology 134, 103-112, 2021 | 1473 | 2021 |
| Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Revista española de cardiología 74 (9), 790-799, 2021 | 1304 | 2021 |
| Research methods EW Kane The Gender Trap, 219-236, 2012 | 1290 | 2012 |
| Reducing waste from incomplete or unusable reports of biomedical research P Glasziou, DG Altman, P Bossuyt, I Boutron, M Clarke, S Julious, ... The Lancet 383 (9913), 267-276, 2014 | 1262 | 2014 |
| A revised tool for assessing risk of bias in randomized trials JPT Higgins, JAC Sterne, J Savovic, MJ Page, A Hróbjartsson, I Boutron, ... Cochrane database of systematic reviews 10 (Suppl 1), 29-31, 2016 | 1259 | 2016 |
| CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts I Boutron, DG Altman, D Moher, KF Schulz, P Ravaud, ... Annals of internal medicine 167 (1), 40-47, 2017 | 1155 | 2017 |
| Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes I Boutron, S Dutton, P Ravaud, DG Altman Jama 303 (20), 2058-2064, 2010 | 780 | 2010 |
| Comparison of registered and published primary outcomes in randomized controlled trials S Mathieu, I Boutron, D Moher, DG Altman, P Ravaud Jama 302 (9), 977-984, 2009 | 768 | 2009 |
| CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ... PLoS medicine 5 (1), e20, 2008 | 742 | 2008 |
| Challenges in evaluating surgical innovation PL Ergina, JA Cook, JM Blazeby, I Boutron, PA Clavien, BC Reeves, ... The Lancet 374 (9695), 1097-1104, 2009 | 681 | 2009 |
| Evaluation and stages of surgical innovations JS Barkun, JK Aronson, LS Feldman, GJ Maddern, SM Strasberg The Lancet 374 (9695), 1089-1096, 2009 | 610 | 2009 |
| Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments I Boutron, D Moher, DG Altman, KF Schulz, P Ravaud, CONSORT Group* Annals of internal medicine 148 (4), W-60-W-66, 2008 | 570 | 2008 |
Douglas G AltmanCentre for Statistics in Medicine, University of OxfordVerified email at csm.ox.ac.uk
